IUPAC Name: 5-[2-[4-(1,3-Benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamidehydrochloride 
Following is the structure of Medroxalol hydrochloride (CAS NO.70161-10-3):
                   
Empirical Formula: C₂₀H₂₅ClN₂O₅
Molecular Weight: 408.8759 g/mol
EINECS: 274-347-3
Flash Point: 319.1 °C
Enthalpy of Vaporization: 94.47 kJ/mol
Boiling Point: 604.1 °C at 760 mmHg
Vapour Pressure of Medroxalol hydrochloride (CAS NO.70161-10-3): 1.92E-15 mmHg at 25 °C
Canonical SMILES: CC(CCC1=CC2=C(C=C1)OCO2)NCC(C3=CC(=C(C=C3)O)C(=O)N)O.Cl
InChI: InChI=1S/C20H24N2O5.ClH/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25;/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25);1H
InChIKey: YYWISFWLJSVFOF-UHFFFAOYSA-N

Questionable carcinogen with experimental neoplastigenic data reported. When heated to decomposition, Medroxalol hydrochloride (CAS NO.70161-10-3) emits toxic vapors of NO_x and HCl.

 Medroxalol hydrochloride , its cas register number is 70161-10-3. It also can be called 5-(1-Hydroxy-2-((1-methyl-3-(3,4-(methylenedioxy)phenyl)propyl)amino)ethyl)salicylamide monohydrochloride ; 5-(2-((3-(1,3-Benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxybenzamide HCl ; Medroxalol HCl ; and Benzamide, 5-(2-((3-(1,3-benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxy-, monohydrochloride . Its classification code are Antihypertensive; Drug / Therapeutic Agent and Tumor data. Medroxalol hydrochloride (CAS NO.70161-10-3) is an antihypertensive agent with beta 1 adrenergic cardiac blocking properties, and beta 2 and some alpha 1 vasodilating activity.